1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARS PHARMACEUTICALS INC
ARS Pharmaceuticals Inc
XNAS: SPRY

ARS Pharma Inc Live Stock Price Today, Share Analysis and Chart

Expensive Underperformer
about

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intra...

Read More
8.39 0.15 (1.82%)
55.61% Fall from 52W High
1.0M
XNAS Volume

XNAS 13 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for ARS Pharma Inc is on 22 Mar 2026 for the purpose of 38th Annual ROTH Conference See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Expensive Valuation
16.2 / 100
Momentum Score
Technically Bearish
28.1 / 100
Expensive Underperformer These stocks have average quality, expensive valuations and weak momentum. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
27
1Yr Price target upside is 222%
6 analysts

11

S

10

W

7

O

0

T

SWOT Analysis

ARS Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..